These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14604461)

  • 21. Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor.
    De Bartolo L; Salerno S; Morelli S; Giorno L; Rende M; Memoli B; Procino A; Andreucci VE; Bader A; Drioli E
    Biomaterials; 2006 Sep; 27(27):4794-803. PubMed ID: 16753210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of porcine hepatocytes in three-dimensional bioreactor at room temperature using epigallocatechin-3-gallate.
    Miskon A; Yamaoka T; Hyon SH; Kodama M; Uyama H
    Tissue Eng Part C Methods; 2009 Sep; 15(3):345-53. PubMed ID: 19196126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A flexible bioreactor system for constructing in vitro tissue and organ models.
    Vozzi F; Mazzei D; Vinci B; Vozzi G; Sbrana T; Ricotti L; Forgione N; Ahluwalia A
    Biotechnol Bioeng; 2011 Sep; 108(9):2129-40. PubMed ID: 21495015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioengineering of liver assist devices.
    Tilles AW; Berthiaume F; Yarmush ML; Tompkins RG; Toner M
    J Hepatobiliary Pancreat Surg; 2002; 9(6):686-96. PubMed ID: 12658402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a bioreactor with stacked sheet shaped organoids of primary hepatocytes.
    Kusumi T; Ishihara K; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
    J Biosci Bioeng; 2009 May; 107(5):552-5. PubMed ID: 19393557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The optimal hepatocyte density for a hollow-fiber bioartificial liver.
    Xu Q; Sun X; Qiu Y; Zhang H; Ding Y
    Ann Clin Lab Sci; 2004; 34(1):87-93. PubMed ID: 15038673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolation and culture of pig hepatocyte in large scale for the application of bioartificial liver system].
    Chung YJ; Lee HJ; Koh YT; Kim SB; Kim SH; Choi SH; Yi NJ; Chang SH; Yang EL; Suh KS; Lee YS; Lee KU
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):249-55. PubMed ID: 12499781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemoglobin regulates the metabolic and synthetic function of rat insulinoma cells cultured in a hollow fiber bioreactor.
    Gundersen SI; Chen G; Powell HM; Palmer AF
    Biotechnol Bioeng; 2010 Oct; 107(3):582-92. PubMed ID: 20552668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galactose-carrying polymers as extracellular matrices for liver tissue engineering.
    Cho CS; Seo SJ; Park IK; Kim SH; Kim TH; Hoshiba T; Harada I; Akaike T
    Biomaterials; 2006 Feb; 27(4):576-85. PubMed ID: 16084586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propagation and functional characterization of serum-free cultured porcine hepatocytes for downstream applications.
    Schneider C; Aurich H; Wenkel R; Christ B
    Cell Tissue Res; 2006 Mar; 323(3):433-42. PubMed ID: 16315006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct self-assembly of hepatocytes spheroids within hollow fibers in presence of collagen.
    Meng Q; Wu D; Zhang G; Qiu H
    Biotechnol Lett; 2006 Feb; 28(4):279-84. PubMed ID: 16555013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidic platform for hepatitis B viral replication study.
    Sodunke TR; Bouchard MJ; Noh HM
    Biomed Microdevices; 2008 Jun; 10(3):393-402. PubMed ID: 18165913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor.
    Memoli B; De Bartolo L; Favia P; Morelli S; Lopez LC; Procino A; Barbieri G; Curcio E; Giorno L; Esposito P; Cozzolino M; Brancaccio D; Andreucci VE; d'Agostino R; Drioli E
    Biomaterials; 2007 Nov; 28(32):4836-44. PubMed ID: 17706279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a hollow fiber bioartificial liver device.
    Abu-Absi SF; Seth G; Narayanan RA; Groehler K; Lai P; Anderson ML; Sielaff T; Hu WS
    Artif Organs; 2005 May; 29(5):419-22. PubMed ID: 15854219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of technologies for hepatic tissue engineering.
    Nahmias Y; Berthiaume F; Yarmush ML
    Adv Biochem Eng Biotechnol; 2007; 103():309-29. PubMed ID: 17195468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioreactors for tissue mass culture: design, characterization, and recent advances.
    Martin Y; Vermette P
    Biomaterials; 2005 Dec; 26(35):7481-503. PubMed ID: 16023202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of steady-state oxygen gradients in vitro: application to liver zonation.
    Allen JW; Bhatia SN
    Biotechnol Bioeng; 2003 May; 82(3):253-62. PubMed ID: 12599251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Design of a hollow-fiber bioreactor and perfusion study in vitro].
    Shu G; Song J; Du Z; Li T; Zhang J; Cui R; Fu L; Lü W; Bi H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):166-9. PubMed ID: 16532833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
    Navas JM; Segner H
    Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.